the number of patients
... the stratification process, thorough clinical examination of the patient plays a fundamental part in the diagnosis, risk stratification and implication of appropriate clinical strategies designed on the received data. The aim of the article is to examine stratification of the risk factors for cardio ...
... the stratification process, thorough clinical examination of the patient plays a fundamental part in the diagnosis, risk stratification and implication of appropriate clinical strategies designed on the received data. The aim of the article is to examine stratification of the risk factors for cardio ...
Current practice of cardiac resynchronization therapy (CRT) in the
... atrial fibrillation may profit from CRT,7 but evidence from large trials is lacking as this particular patient group was generally excluded. Controversy currently exists, however, regarding the necessity of AV nodal ablation, of ablation of atrial fibrillation itself, concomitant rate- or rhythm-con ...
... atrial fibrillation may profit from CRT,7 but evidence from large trials is lacking as this particular patient group was generally excluded. Controversy currently exists, however, regarding the necessity of AV nodal ablation, of ablation of atrial fibrillation itself, concomitant rate- or rhythm-con ...
AMeRiCAn College of CARdiology CongRess 2017
... Electrical cardioversion in patients with AF of less than 48 hours duration is usually regarded as a low-risk procedure. A study reported that there is risk associated with this approach as systemic embolism does occur. It was suggested that the risk may be lower in patients with a CHADSVaSC score < ...
... Electrical cardioversion in patients with AF of less than 48 hours duration is usually regarded as a low-risk procedure. A study reported that there is risk associated with this approach as systemic embolism does occur. It was suggested that the risk may be lower in patients with a CHADSVaSC score < ...
Diastolic Pressure Gradient€Predicts Outcome in€Patients With
... with these 2 patients considered nonpure myectomies, the Mayo mortality rate would be only 0.15%. §Includes 19% of patients with mitral valve repair. kNewest myectomy center with operations performed over only 11 years with first procedure in 2004, whereas data for the other centers encompass 15 year ...
... with these 2 patients considered nonpure myectomies, the Mayo mortality rate would be only 0.15%. §Includes 19% of patients with mitral valve repair. kNewest myectomy center with operations performed over only 11 years with first procedure in 2004, whereas data for the other centers encompass 15 year ...
VAD Strategies and Outcomes in Congenital Heart Disease
... setting of progressive heart failure, usually after previous cardiac surgery. Rarely, long term “Destination” therapy ...
... setting of progressive heart failure, usually after previous cardiac surgery. Rarely, long term “Destination” therapy ...
Amr Ali Esmail _Isoflurane_preconditioning
... Patients were randomly categorized into 2 equal groups (n=30) according to the type of anesthetic used for maintenance: Midazolam group received a continuous infusion of midazolam 0.2 mg/kg/hour and Isoflurane group maintained by an end-tidal concentration of isoflurane of 1-1.5%throughout the opera ...
... Patients were randomly categorized into 2 equal groups (n=30) according to the type of anesthetic used for maintenance: Midazolam group received a continuous infusion of midazolam 0.2 mg/kg/hour and Isoflurane group maintained by an end-tidal concentration of isoflurane of 1-1.5%throughout the opera ...
Atrial fibrillation Patient Information Leaflet
... hospital. Otherwise, it is best delayed for at least 4 weeks to ensure that any possible clots in the heart have dissolved. Although cardioversion is generally effective, it does not work in some patients, especially those who have been in AF a long time, are very overweight, have underlying heart d ...
... hospital. Otherwise, it is best delayed for at least 4 weeks to ensure that any possible clots in the heart have dissolved. Although cardioversion is generally effective, it does not work in some patients, especially those who have been in AF a long time, are very overweight, have underlying heart d ...
Managing the High Risk Patient
... intraventricular conduction delay, which may lead to dyssynchrony of cardiac contraction and further clinical impairment The patients in this clinical trial were randomly assigned to a group receiving resynchronization therapy with an atrial-biventricular pacemaker or to a control group As compared ...
... intraventricular conduction delay, which may lead to dyssynchrony of cardiac contraction and further clinical impairment The patients in this clinical trial were randomly assigned to a group receiving resynchronization therapy with an atrial-biventricular pacemaker or to a control group As compared ...
Medtronic-Supported Clinical Trial Shows ICD Patients Less
... “Strong clinical evidence supporting the positive outcomes that MVP can have in pacemaker patients already exists,” said Marshall Stanton, M.D., vice president of clinical research for the Cardiac Rhythm Disease Management business at Medtronic. “The analysis presented today shows that MVP reduces t ...
... “Strong clinical evidence supporting the positive outcomes that MVP can have in pacemaker patients already exists,” said Marshall Stanton, M.D., vice president of clinical research for the Cardiac Rhythm Disease Management business at Medtronic. “The analysis presented today shows that MVP reduces t ...
Severe Tricuspid Valve Regurgitation Is Not an Innocent Finding to
... the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American College of Cardiology. From the yDepartment of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio; zDepartment of Cardiovascular Medicine, Heart an ...
... the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American College of Cardiology. From the yDepartment of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio; zDepartment of Cardiovascular Medicine, Heart an ...
2009 - Dr. Dhiren Shah
... and is it done on a routine basis? Dr. Dhiren Shah : Hybrid revascularization entails performing both a PCI procedure and the surgical grafting of the LIMA to the LAD, using a minimally i n v a s i v e a p p r o a c h , typically within one to two days of each other. As there is still no alternative ...
... and is it done on a routine basis? Dr. Dhiren Shah : Hybrid revascularization entails performing both a PCI procedure and the surgical grafting of the LIMA to the LAD, using a minimally i n v a s i v e a p p r o a c h , typically within one to two days of each other. As there is still no alternative ...
The Heart - Northern Highlands
... 2. How many times per minute does the human heart beat, how many times per day, and how many gallons of blood are pumped each day by the heart? ...
... 2. How many times per minute does the human heart beat, how many times per day, and how many gallons of blood are pumped each day by the heart? ...
The Annals of Thoracic Surgery
... +/- 0.3 to 0.9 +/- 0.5 (p < 0.001). Left ventricular end-diastolic volume (79.6 +/- 23.6 to 61.2 +/- 16.9 mL; p = 0.004) and end-systolic volume (63.1 +/- 17.3 to 49.2 +/12.3 mL; p = 0.006) decreased substantially. End-systolic elastance significantly increased from 1.9 +/- 1.0 to 2.6 +/- 1.4 mm Hg/ ...
... +/- 0.3 to 0.9 +/- 0.5 (p < 0.001). Left ventricular end-diastolic volume (79.6 +/- 23.6 to 61.2 +/- 16.9 mL; p = 0.004) and end-systolic volume (63.1 +/- 17.3 to 49.2 +/12.3 mL; p = 0.006) decreased substantially. End-systolic elastance significantly increased from 1.9 +/- 1.0 to 2.6 +/- 1.4 mm Hg/ ...
The Thoratec System Implanted as a Modified Total Artificial Heart
... The CardioWest™ temporary total artificial heart (SynCardia Systems, Tucson, AZ, USA) is the world’s first and only FDA-approved total artificial heart (TAH). It received FDA approval in October 2004 following a 10-year pivotal clinical study. The TAH orthotopically replaces both native cardiac ventric ...
... The CardioWest™ temporary total artificial heart (SynCardia Systems, Tucson, AZ, USA) is the world’s first and only FDA-approved total artificial heart (TAH). It received FDA approval in October 2004 following a 10-year pivotal clinical study. The TAH orthotopically replaces both native cardiac ventric ...
Heart failure with preserved and reduced ejection fraction: different
... HFpEF by EF ≥ 50%, meaning that the ‘middle group’ (EF 41– 49%) was excluded, though it is notable that only 1.3% of all HF subjects fell in this range. During the study period, 374 people developed HF (4.4%) of which 66% had HFrEF and 34% had HFpEF. The average time to diagnosis was 7.2 years, but ...
... HFpEF by EF ≥ 50%, meaning that the ‘middle group’ (EF 41– 49%) was excluded, though it is notable that only 1.3% of all HF subjects fell in this range. During the study period, 374 people developed HF (4.4%) of which 66% had HFrEF and 34% had HFpEF. The average time to diagnosis was 7.2 years, but ...
Update on b-Blockers In the Management of Heart
... No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea, or angina. Slight limitation of physical activity. Ordinary physical activity results in fatigue, palpitation, dyspnea, or angina. ...
... No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea, or angina. Slight limitation of physical activity. Ordinary physical activity results in fatigue, palpitation, dyspnea, or angina. ...
Risk of heart failure following Hodgkin lymphoma
... M Average mean left ventricular dose (MLVD) was not significantly different between case patients and control patients M There was a marked increase in the risk for HF even at lower doses, up to 25 Gy of mean heart dose (MHD) or up to 15 Gy of MLVD M The 25-year cumulative risks for HF after MLVDs of ...
... M Average mean left ventricular dose (MLVD) was not significantly different between case patients and control patients M There was a marked increase in the risk for HF even at lower doses, up to 25 Gy of mean heart dose (MHD) or up to 15 Gy of MLVD M The 25-year cumulative risks for HF after MLVDs of ...
Limiting Infarct Size in ST-Segment Myocardial Infarction
... They concluded that mechanical preconditioning of *Editorials published in JACC: Heart Failure reflect the views of the ...
... They concluded that mechanical preconditioning of *Editorials published in JACC: Heart Failure reflect the views of the ...
Common Arrhythmias in Dogs and Cats
... fibrillate, the ventricle lose this extra “kick” from the atria, and this will lead to less filling of the ventricles, and less forceful of a contraction. Typically the heart rate is extremely fast and irregular during atrial fibrillation, and patients may have heart rates above 200-220 beats-per-mi ...
... fibrillate, the ventricle lose this extra “kick” from the atria, and this will lead to less filling of the ventricles, and less forceful of a contraction. Typically the heart rate is extremely fast and irregular during atrial fibrillation, and patients may have heart rates above 200-220 beats-per-mi ...
Diastolic congestive heart failure: Treatment is moving to the `burbs
... (congestive heart failure) thought only to be due the relaxation abnormality of the heart Soon became clear that it is not simply the opposite end of the spectrum in comparison to systolic CHF It is not simply a stiff left ventricle but a stiff ventricle along with a stiff arterial and venous system ...
... (congestive heart failure) thought only to be due the relaxation abnormality of the heart Soon became clear that it is not simply the opposite end of the spectrum in comparison to systolic CHF It is not simply a stiff left ventricle but a stiff ventricle along with a stiff arterial and venous system ...
3 PAPERs, 1 DIsEAsE ALso Inflammatory Bowel Disease
... older patients and as researchers identify a growing number M-LINE To refer a patient to the Cardio-Oncology clinic,call of cardiovascular side effects of anti-cancer therapy. CareM-LINE at 800-962-3555. ful evaluation of heart disease in cancer patients will likely improve quality of life but may a ...
... older patients and as researchers identify a growing number M-LINE To refer a patient to the Cardio-Oncology clinic,call of cardiovascular side effects of anti-cancer therapy. CareM-LINE at 800-962-3555. ful evaluation of heart disease in cancer patients will likely improve quality of life but may a ...
Outcome of patients with ST segment elevation myocardial infarction
... to all causes among the 197 patients, of which, 13 were cardiac related deaths. Kaplan-Meier survival curve was generated for all deaths (Figure 1). The 3-year survival probability of these patients from deaths due to all causes was 82.7% (95% CI 75.8-89.6), and from cardiovascular related deaths wa ...
... to all causes among the 197 patients, of which, 13 were cardiac related deaths. Kaplan-Meier survival curve was generated for all deaths (Figure 1). The 3-year survival probability of these patients from deaths due to all causes was 82.7% (95% CI 75.8-89.6), and from cardiovascular related deaths wa ...